Prozac At-Home Withdrawal and Tapering Program
Prozac has the longest half-life of any antidepressant, or the length of time it takes to leave the body. Prozac targets Serotonin, the neurotransmitter found primarily in the gastrointestinal tract, blood platelets and throughout the central nervous system. This explains why the side effect profile of Prozac can affect so many systems of the body. Weaning off Prozac must be done slowly to provide ample opportunity for the readjustment of the Serotonin receptors.  Due to the long half life, many do not realize the extent of the Prozac withdrawal length / duration and that they are in serious withdrawal for weeks after stopping Prozac, then the nightmares, insomnia, anxiety, reoccurrence of depression and other common Prozac Withdrawal symptoms emerge. Prozac is often used as a bridge to prevent SSRI withdrawals, but many do not respond well to Prozac or have serotonin levels increase out of safe ranges from combining Prozac with their other antidepressant. Our nonprofit has spent over 17 years helping people taper Prozac and all antidepressants properly. We focus on healing during the tapering process and are careful to ensure no interactions items are used that could put you at risk. Contact our nonprofit for help to taper off Prozac.*
Below is information about Prozac, Prozac withdrawal, and how to stop taking Prozac naturally.
WHAT IS PROZAC WITHDRAWAL LIKE?
PROZAC WITHDRAWAL HELP - WEANING OFF PROZAC
Over the last 17 years Point of Return has helped people all over the world to escape dependence to addictive medications. Although Prozac is a long-acting antidepressant, meaning the Prozac withdrawal length or duration is longer than other antidepressants, weaning off slowly is recommended to control Prozac Withdrawals commonly called the Prozac Discontinuation Syndrome.  The Point of Return Program is a proven, holistic approach that allows you to step down on Prozac while helping to ease symptoms and promoting sleep with supplements that will not interact, yet provide the necessary relief. Your Prozac at-home weaning program is done under the guidance of Our Team, Your Physician and Pharmacist, and allows you to wean off Prozac at rates not available by the pharmaceutical companies. Our pre-taper is for Prozac symptom relief - you will not taper Prozac until you feel better. This is where our advanced nutraceuticals and holistic approach are critical due to the unique demands placed on your body and nervous system by the Prozac. Point of Return provides healthy, proven, Drug-Free strategies to help ease Prozac Withdrawal symptoms while supporting your well being.*
Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis. Our innovative approach to antidepressant tapering encompasses a holistic method to empower you on your path to recovery.
No need to attempt Prozac Withdrawal on your own, work with us.*
PROZAC WITHDRAWAL SYMPTOMS MAY INCLUDE
- severe headache
- burning or tingling sensations around the body
- brain zaps / brain shivers
- rushing noise in the head
- concentration problem
- reduced appetite
- excessive dreaming
- gastrointestinal issues 
IMAGINE BEING FREE OF PROZAC DEPENDENCY
✔ Proven Program completed At-Home
✔ Slowly Stop Taking Prozac
✔ All-Natural Nutraceuticals to help ease symptoms and make Prozac Withdrawal more comfortable*
✔ Professional information on interactions
✔ Free Mentoring on our 24/7 private Discussion Board
Enter Discount Code ADFree for FREE Ground Shipping on your Withdrawal Program (USA & Canada Only)
PROZAC WITHDRAWAL LENGTH / TIMELINE
The half-life of Prozac, or the time to clear the body, is the longest for any antidepressant, approximately 4-6 days for the active metabolite and 30 days to fully leave the body.  However, this does not mean that all withdrawal symptoms start after a month. Many feel even a small reduction in Prozac since it is estimated that 56% of people experience withdrawal effects with 46% reporting severe symptoms. One study found that 67% of people taking Prozac experienced withdrawal symptoms including a feeling of detachment, electric shock in the head (brain zaps), anxiety, depression, gastrointestinal disturbances, flu-like symptoms, and many others. Please, do not attempt to stop Prozac on your own. Contact our Prescription Drug Experts who have assisted people in 87 countries to regain their lives. Contact us today!
PROZAC WITHDRAWAL SUCCESS STORIES
I Thank you Point of Return for all of your patience and kindness. We in a fragile state need your extra kindness. Thank you for all you have done for me and my roach to recovery. More...
Betty (Prozac Withdrawal Success Story)
I also need to thank the whole Point of Return staff. I called many times looking for help and always got an uplifting word or laugh. For those currently struggling, try their withdrawal program. Give the Point of Return team a call or email. More...
Eric (Prozac Withdrawal Success Story)
I have found that if you work the Point of Return program that it will work for you. The results are there if you do your part and work the program. I strongly recommend Point of Return to others. More...
Rachel (Prozac Withdrawal Success Story)
PROZAC SIDE EFFECTS AND ADVERSE REACTIONS
PROZAC SIDE EFFECTS MAY INCLUDE:
Abnormal dreams, abnormal ejaculation, abnormal vision, anxiety, diminished sex drive, dizziness, dry mouth, flu-like symptoms, flushing, gas, headache, impotence, insomnia, itching, loss of appetite, nausea, nervousness, rash, sinusitis, sleepiness, sore throat, sweating, tremors, upset stomach, vomiting, weakness, yawning, abnormal taste, agitation, bleeding problems, chills, confusion, ear pain, emotional instability, fever, frequent urination, high blood pressure, increased appetite, loss of memory, palpitations, ringing in the ears, sleep disorders, weight gain
PROZAC ADVERSE REACTIONS MAY INCLUDE: per PDR
Severe: visual impairment, tardive dyskinesia, suicidal ideation, arrhythmia exacerbation, heart failure, myocardial infarction, proteinuria, seizures, peptic ulcer, hematemesis, GI bleeding, pancreatitis, cholecystitis, esophageal ulceration, GI obstruction, muscle paralysis, pulmonary hypertension, thrombosis, ventricular fibrillation, coronary vasospasm, stroke, atrial fibrillation, cardiac arrest, bradycardia, pneumothorax, apnea, pulmonary edema, laryngeal edema, ocular hypertension, hearing loss, oliguria, diabetic ketoacidosis, hyperkalemia, torticollis, thrombotic thrombocytopenic purpura (TTP, aplastic anemia, hemolytic anemia, SIADH, torsade de pointes, ventricular tachycardia, erythema nodosum, pulmonary fibrosis, lupus-like symptoms, bronchospasm, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, anaphylactoid reactions, angioedema, serum sickness, vasculitis,Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), laryngospasm, toxic epidermal necrolysis, eosinophilic pneumonia, pulmonary embolism, optic neuritis, hepatic failure, hepatic necrosis, renal failure (unspecified), bone fractures, serotonin syndrome, persistent pulmonary hypertension of the newborn, neonatal abstinence syndrome
Moderate: impotence (erectile dysfunction), ejaculation dysfunction, constipation, oral ulceration, melena, esophagitis, cholelithiasis, dysphagia, glossitis, gastritis, colitis, stomatitis, neuropathic pain, myoclonia, teeth grinding (bruxism), migraine, akathisia, ataxia, hypertonia, hostility, psychosis, euphoria, depression, anemia, hypotension, angina, orthostatic hypotension, peripheral edema, edema, vaginal bleeding, atopic dermatitis, skin ulcer, photophobia, conjunctivitis, elevated hepatic enzymes, urinary incontinence, dysuria, hematuria, urinary retention, cystitis, hypothyroidism, hypercholesterolemia, dehydration, hypokalemia, hyperlipidemia, gout, bone pain, synovitis, mania, abdominal pain, fecal incontinence, neuritis, hallucinations, EEG changes, dysarthria, hyperesthesia, dystonic reaction, lymphocytosis, thrombocytopenia, leukopenia, phlebitis, priapism, psoriasis, furunculosis, hypoxia, hypoventilation, hemoptysis, blepharitis, iritis, exophthalmos, hyperacusis, hepatitis, flank pain, glycosuria, hyperglycemia, diabetes mellitus, hypocalcemia, hyperuricemia, myopathy, myasthenia, osteoporosis, confusion, amnesia, QT prolongation, hypertension, palpitations, chest pain (unspecified), dyskinesia, memory impairment, impulse control symptoms, hematoma, bleeding, platelet dysfunction, hyponatremia, galactorrhea, hyperprolactinemia, dyspnea, cataracts, jaundice, hypoglycemia, osteopenia, withdrawal, growth inhibition
Mild: insomnia, nausea, headache, asthenia, diarrhea, anorexia, drowsiness, anxiety, tremor, xerostomia, yawning, libido decrease, dyspepsia, pharyngitis, dizziness, hyperhidrosis, urticaria, rash, sinusitis, abnormal dreams, flushing, flatulence, vomiting, pruritus, weight loss, epistaxis, fever, hypersalivation, polydipsia, eructation, paranoia, vertigo, hypoesthesia, ecchymosis, syncope, breast enlargement, orgasm dysfunction, mastalgia, menorrhagia, libido increase, breast discharge, amenorrhea, leukorrhea, photosensitivity, alopecia, maculopapular rash, skin discoloration, acne vulgaris, malaise, hyperventilation, hiccups, mydriasis, xerophthalmia, polyuria, urinary urgency, nocturia, pelvic pain, arthralgia, muscle cramps, paresthesias, hyporeflexia, petechiae, purpura, pallor, hirsutism, seborrhea, parosmia, diplopia, appetite stimulation, weight gain, dysgeusia, emotional lability, hyperkinesis, agitation, hypothermia, chills, otalgia, tinnitus, increased urinary frequency, gynecomastia, influenza
PROZAC BOXED WARNINGS: per PDR:
Children, growth inhibition, suicidal ideation
Fluoxetine is approved for the treatment of depression in children 8 years of age and older, and for the treatment of obsessive-compulsive disorder (OCD) in children 7 years of age and older. The safety and effectiveness of fluoxetine in younger children have not been established. In October 2004, the FDA directed manufacturers of all antidepressants to include a boxed warning detailing the risk of suicide in pediatric patients. A causal role has been established for antidepressants in inducing suicidality in pediatric patients. The risk of suicidality for these drugs was identified in a pooled analysis of 24 placebo-controlled trials (n=4400) lasting up to 16 weeks in pediatric patients with major depressive disorder (MDD), obsessive compulsive disorder (OCD), or other psychiatric disorders. The analysis showed a greater risk of suicidality during the first few months of treatment in those receiving antidepressants (SSRIs and others). The average risk of such events on drug was 4% and 2% for placebo; however, no suicides occurred in these trials. Pooled analysis of short-term clinical trials during early phase treatment with SSRIs and other antidepressants in young adults (18 to 24 years) also showed an increased risk of suicidal thinking and behavior. The clinical need for an antidepressant in children or young adults for any use must be weighed against the risk of increased suicidality; patients who are started on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior, particularly within the first few months of starting therapy or at the time of dose increase or decrease. It is unknown if the suicidality risk in children and young adults extends to longer-term therapy (i.e., beyond several months). The possibility of a suicide attempt is inherent in patients with depressive symptoms, whether these occur in primary depression or in association with another primary disorder. All patients with a history of suicidal ideation or behaviors and those with a prominence of suicidal ideation prior to treatment are considered at an increased risk for suicidal ideation or attempts, and should be closely monitored during treatment with fluoxetine. In patients who exhibit changes in symptoms, worsening of depression or emergent suicidality, a decision should be made to change or discontinue treatment. If discontinuing, medication should be tapered as rapidly as possible, but with recognition that abrupt discontinuation can also cause adverse symptoms. All antidepressants should be prescribed in the smallest quantity consistent with good patient management in order to reduce the risk of overdose. The potential for growth inhibition in pediatric patients should be monitored during SSRI therapy. Monitor height and weight periodically while the patient is receiving fluoxetine. Data are inadequate to determine whether the chronic use of SSRIs causes long-term growth inhibition; however, decreased weight gain has been observed in children and adolescents receiving fluoxetine.
PROZAC TECHNICAL DATA AND REFERENCES
Discontinuation According to the FDA:
Treatment Patients should be advised to take PROZAC exactly as prescribed, and to continue taking PROZAC as prescribed even after their symptoms improve.
Patients should be advised that they should not alter their dosing regimen, or stop taking PROZAC without consulting their physician [see Warnings and Precautions (5.15)]. Patients should be advised to consult with their healthcare provider if their symptoms do not improve with PROZAC.
If the decision has been made to discontinue treatment, medication should be tapered, as rapidly as is feasible, but with recognition that abrupt discontinuation can be associated with certain symptoms [see Warnings and Precautions
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements/info on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with Your physician to help you with your drug withdrawal process and with his or her consent throughout.
*This program is not meant to cure or prevent any disease or illness.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support throughout the process. More..